Healthcare's defensive demand is strengthening in 2026. BTSG, HRMY, UNH and NVCR stand out on improv

Stocks like SNX, AMP, HRMY and NWL are seeing price strength and have a high chance of carrying the

PLYMOUTH MEETING, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq:

Harmony Biosciences (NASDAQ: HRMY) reported second-quarter net revenue of $261.3 million, up 30% fro

Harmony Biosciences Holdings, Inc. has now elevated BP-205, its orexin-2 receptor agonist, to lead t

HRMY tops Q2 estimates as Wakix demand fuels 30% revenue growth. A growing pipeline, BP-205 progress

Harmony Biosciences (HRMY) could produce exceptional returns because of its solid growth attributes.

Harmony Biosciences Holdings, Inc. (HRMY) Q2 2026 Earnings Call Transcript

Harmony Biosciences NASDAQ: HRMY reported second-quarter net revenue of $261.3 million, up 30% from

Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $1.28 per share, beati

WAKIX® Net Revenue Grew 30% Year over Year to $261.3 Million for Second Quarter 2026; Estimated Aver

With the Fed holding rates steady and Middle East tensions clouding market sentiment, ARW, PENN, GOO

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Harmony Biosciences, Invesco, GM, HPE and Quanex made the screen of low price-to-book stocks that al

Harmony Biosciences (HRMY) is evolving from a single-product firm into a self-funded neuroscience pl

Harmony Biosciences (HRMY) possesses the right combination of the two key ingredients for a likely e

Harmony Biosciences, Acadia, Biogen, Insmed and Agios show positive Earnings ESPs ahead of Q2 result

Harmony Biosciences (HRMY) was a big mover last session on higher-than-average trading volume. The l

PLYMOUTH MEETING, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq:

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Harmony Biosciences Hldgs (NASDAQ:

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced preliminary, unaudited second quart

Harmony Biosciences Hldgs (NASDAQ:HRMY) affirms prelim FY2026 sales outlook from $1.000 billion-$1.0

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings

Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third q

Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for it

  During Tuesday, 95 stocks hit new 52-week lows.

Gainers

U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Tuesday. Here are some big

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f

Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.

Upgrades

  Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to repo

  Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for it

  Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report e

Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the c